![](/img/cover-not-exists.png)
Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy treatment
Starling, N, Tilden, D, White, J, Cunningham, DVolume:
96
Year:
2007
Language:
english
Pages:
7
DOI:
10.1038/sj.bjc.6603561
File:
PDF, 177 KB
english, 2007